Optisure Lead Post Approval Study
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Abbott Medical Devices
- Study ID
- NCT02235545
- Status
- Terminated
Conditions
- Heart Failure
- Tachycardia, Ventricular
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- St. Jude Medical Optisure Lead — DEVICEPatients implanted with St. Jude Medical Optisure Lead
Study Details
The purpose of this post approval study is to characterize the chronic performance of the SJM Optisure family of HV leads in patients.
Key Dates
- Start date
- Aug 31, 2014
- Status verified
- Jul 2025
- Primary completion
- Dec 16, 2019
- Completion
- Jun 30, 2020
Study Design
- Enrollment
- 1,735 participants (actual)
Arms
- Arm: St. Jude Medical Optisure LeadPatients implanted with St. Jude Medical Optisure Lead
Primary Outcome Measure
Complication Free Survival Rate at 5 Years for Complications Related to the Optisure RV Leads. [ Time Frame: 5 years ]
Locations (46)
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Baptist Medical Center Princeton· Birmingham, ALPhoenix Cardiovascular Research Group· Phoenix, AZSt. Bernards (formerly Cardiology Associates of Northeast Arkansas)· Jonesboro, ARRaymond Schaerf, MD· Burbank, CADesert Heart Rhythm Consultants· Palm Springs, CACardiac Rhythm Specialists, Inc.· Reseda, CA
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft TissuesRecruiting · Arunark Kolipaka · Columbus, Ohio
- Cardiovascular Health Improvement ProjectRecruiting · University of Michigan · Ann Arbor, Michigan